
Dagmar Scheel-Toelln
@d_scheel
Interested in how chronic inflammation develops. Drug development. B cells. Rheumatoid arthritis. And much more
ID: 1107189619
20-01-2013 20:09:13
322 Tweet
86 Takipçi
188 Takip Edilen

Understanding what risk/benefit trade-offs are acceptable to patients is important in drug development. How best to assess this? Our paper compares two methods for measuring patient preferences. Birmingham Rheumatology Research Group Inflammation and Ageing NIHR Birmingham Biomedical Research Centre PREFER: patient preferences pubmed.ncbi.nlm.nih.gov/37647010/



The awesome power of Birmingham Tissue Analytics multidimensional digital histology and Ai platforms being showcased by our Technicians Chelsea, Dawn, Jordanne and Nayandeep Inflammation and Ageing RACE GBN Birmingham Rheumatology Research Group



🔥 Just out! 📷 In today's publication by BMC Series , we present the Student Patient Alliance. This groundbreaking #PPI initiative, led by Dr Marie Falahee, connects PhD students with patient, revolutionizing collaboration in Birmingham. R2P2 NIHR Birmingham Biomedical Research Centre


It’s a match: Birmingham leads pioneering initiative to partner PhD students and patients birmingham.ac.uk/news/2023/its-… via Uni of Birmingham


I'm thrilled to learn that I've been awarded a Wellcome Trust Early Career Award, which will fund my research for the next 5 years! 🥂🎉 Super excited to work with @SarahDimeloeLab and Immunology and Immunotherapy to understand how mitochondrial regulation controls immune cells in inflammation


We're delighted to award 3 BSI members Lifetime Honorary Membership at #BSI23 BSI Congress & Events in recognition of their outstanding contributions to #immunology ⭐ 🏆2023 Honorary Members🏆 Prof Arne Akbar Akbar Lab Prof Allan Mowat Allan Mowat Dr Gitta Stockinger The Francis Crick Institute


Excited to be attending the RACE Hybrid Scientific meeting today hosted by University of Newcastle! John Isaacs We have some fantastic talks lined up from our RACE GBN colleagues! Kennedy Institute of Rheumatology Birmingham Rheumatology Research Group MRG Newcastle UofG Sii Versus Arthritis

John Isaacs Kennedy Institute of Rheumatology Birmingham Rheumatology Research Group MRG Newcastle UofG Sii Versus Arthritis Iain McInnes chaired session 1 on BIO-FLARE (cells and cytokines) Iain B. McInnes We had some fascinating talks! Here is Dr Dan Maunder @Maunderific1 presenting on scRNA-Seq from BIO-FLARE PBMC


Session 2 – TRAFIC (stroma) chaired by Chris Buckley Christopher Buckley with RACE student Imogen Wilson @Imy_wilsongiving giving a brilliant talk on “The functional consequences of B cell and fibroblasts interactions” 👏


RACE GBN Kennedy Institute of Rheumatology Birmingham Rheumatology Research Group MRG Newcastle UofG Sii Versus Arthritis Absolutely brilliant day of truly cutting edge science. Thanks so much to all presenters and attendees. It’s hard to imagine where you could find a denser concentration of state-of-the-art arthritis research @NHIPartners Newcastle Hospitals Research NIHR Newcastle BRC NIHR Newcastle CRF Newcastle University


Final session - AuToDeCRA-2 (technologies) chaired by Adam Croft April Croft Final year RACE PhD student Jean-Baptiste Richard Jean-Baptiste Richard delivered a very interesting talk on “Matrix-focused multiomic analysis uncovers a novel regulator of the synovial immune landscape” Well done JB!👏


Day 2 Versus Arthritis research fellows conference. Such bright minds & bringing gr8 hope for the future. Prof Matthew Brown, Chief Scientific Officer for Genomics England (funded by us since 1996!) talked about getting closer to a cure for AxSpa. Imagine that. Yes please. 🥰

Well that was a lovely visit to Birmingham Uni/Queen Elizabeth Hospital today, where we Versus Arthritis have made significant investment in research&fellowships. Some gr8 presentations & engaging visit around the labs. Huge thanks for the hospitality and warm welcome.
